Peritoneal cell-derived mast cells: An in vitro model of mature serosal-type mouse mast cells

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6465-6475

  Malbec, Odile ^a,b   Roget, Karine ^a,b   Schiffer, Cécile ^a,b   Iannascoli, Bruno ^a,b   Dumas, Antoine Ribadeau ^b   Arock, Michel ^c   Daëron, Marc ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PHOSPHATASE; PROTEIN SHIP1; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL STRUCTURE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATORY DISEASE; MAST CELL; MOUSE; NONHUMAN; PERITONEUM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 34248219441     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6465     Document Type: Article

References (56)

1. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.
2. Nadler, M. J., S. A. Matthews, H. Turner, and J.-P. Kinet. 2000. Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv. Immunol. 76: 325-355.
3. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
4. Robbie-Ryan, M., M. B. Tanzola, V. H. Secor, and M. A. Brown. 2003. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170: 1630-1634.
5. Miller, H. R., and A. D. Pemberton. 2002. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105: 375-390.
6. Triggiani, M., A. Oriente, G. de Crescenzo, and G. Marone. 1995. Metabolism of lipid mediators in human basophils and mast cells. Chem. Immunol. 61: 135-147.
7. Galli, S. J., J. R. Gordon, and B. K. Wershil. 1991. Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 3: 865-873.
8. Kaplan, A. P. 2001. Chemokines, chemokine receptors and allergy. Int. Arch. Allergy Immunol. 124: 423-431.
9. Gurish, M. F., and J. A. Boyce. 2002. Mast cell growth, differentiation, and death. Clin. Rev. Allergy Immunol. 22: 107-118.
10. Ihle, J. N., J. Keller, S. Oroszlan, L. E. Henderson, T. D. Copeland, F. Fitch, M. B. Prystowsky, E. Goldwasser, J. W. Schrader, E. Palaszynski, et al. 1983. Biologic properties of homogeneous interleukin 3.1. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J. Immunol. 131: 282-287.
11. Galli, S. J., K. M. Zsebo, and E. N. Geissler. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55: 1-96.
12. Welle, M. 1997. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukocyte Biol. 61: 233-245.
13. Turner, H., and J. P. Kinet. 1999. Signalling through the high-affinity IgE receptor FcεRI. Nature 402: B24-B30.
14. Dombrowicz, D., V. Flamand, K. K. Brigman, B. H. Koller, and J.-P. Kinet. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell 75: 969-976.
15. Benhamou, M., C. Bonnerot, W. H. Fridman, and M. Daëron. 1990. Molecular heterogeneity of murine mast cell Fcγ receptors. J. Immunol. 144: 3071-3077.
16. Daëron, M., C. Bonnerot, S. Latour, and W. H. Fridman. 1992. Murine recombinant FcγRIII, but not FcγRII, trigger serotonin release in rat basophilic leukemia cells. J. Immunol. 149: 1365-1373.
17. Hazenbos, L. W., J. E. Gessner, F. M. A. Hofhuis, H. Kuipers, D. Meyer, I. A. F. M. Heijnen, R. E. Schmidt, M. Sandor, P. J. A. Capel, M. Daëron, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5: 181-188.
18. Blank, U., C. Ra, L. Miller, K. White, H. Metzger, and J. P. Kinet. 1989. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 337: 187-189.
19. Kurosaki, T., I. Gander, U. Wirthmueller, and J. V. Ravetch. 1992. The β subunit of the FcεRI is associated with the FcγRIII on mast cells. J. Exp. Med. 175: 447-451.
20. Daëron, M., O. Malbec, S. Latour, M. Arock, and W. H. Fridman. 1995. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 95: 577-585.
21. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379: 346-349.
22. Daëron, M., S. Latour, O. Malbec, E. Espinosa, P. Pina, S. Pasmans, and W. H. Fridman. 1995. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3: 635-646.
23. Ono, M., S. Bolland, P. Tempst, and J. V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383: 263-266.
24. Fong, D. C., O. Malbec, M. Arock, J. C. Cambier, W. H. Fridman, and M. Daëron. 1996. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated FcγRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol. Lett. 54: 83-91.
25. Huber, M., C. D. Helgason, J. E. Damen, L. Liu, R. K. Humphries, and G. Krystal. 1998. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 95: 11330-11335.
26. Wershil, B. K., and S. J. Galli. 1994. The analysis of mast cell function in vivo using mast cell-deficient mice. Adv. Exp. Med. Biol. 347: 39-54.
27. Vaz, N. M., and A. Prouvost-Danon. 1969. Behaviour of mouse mast cells during in vitro anaphylaxis. Progr. Allergy 13: 111-173.
28. Sterk, A. R., and T. Ishizaka. 1982. Binding properties of IgE receptors on normal mouse mast cells. J. Immunol. 128: 838-843.
29. Malbec, O., M. Malissen, I. Isnardi, R. Lesourne, A.-M. Mura, W. H. Fridman, B. Malissen, and M. Daëron. 2004. Linker for activation of T cells integrates positive and negative signaling in mast cells. J. Immunol. 173: 5086-5094.
30. Holmes, K. L., R. G. E. Palfree, U. Hammerling, and H. C. Morse. 1985. Alleles of the Ly-17 alloantigen define polymorphism of a murine IgG Fc receptor. Proc. Natl. Acad. Sci. USA 82: 7706-7710.
31. Liu, F. T., J. W. Bohn, E. L. Ferry, H. Yamamoto, and C. A. Molinaro. 1980. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation and characterization. J. Immunol. 124: 2728-2737.
32. Schiller, C., I. Janssen-Graalfs, U. Baumann, K. Schwerter-Strumpf, S. Izui, T. Takai, R. E. Schmidt, and J. E. Gessner. 2000. Mouse FcγRII is a negative regulator of FcγRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur. J. Immunol. 30: 481-490.
33. Latour, S., C. Bonnerot, W. H. Fridman, and M. Daëron. 1992. Induction of tumor necrosis factor-α production by mast cells via FcγR: role of the FcγRIIIγ subunit. J. Immunol. 149: 2155-2162.
34. Siraganian, R. P. 1974. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem. 57: 383-394.
35. Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J. V. Ravetch. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90: 293-301.
36. Gimborn, K., E. Lessmann, S. Kuppig, G. Krystal, and M. Huber. 2005. SHIP down-regulates FcεRI-induced degranulation at supraoptimal IgE or antigen levels. J. Immunol. 174: 507-516.
37. Takagi, M., T. Nakahata, T. Kubo, M. Shiohara, K. Koike, A. Miyajima, K. Arai, S. Nishikawa, K. M. Zsebo, and A. Komiyama. 1992. Stimulation of mouse connective tissue-type mast cells by hemopoietic stem cell factor, a ligand for the c-kit receptor. J. Immunol. 148: 3446-3453.
38. Karimi, K., F. A. Redegeld, B. Heijdra, and F. P. Nijkamp. 1999. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp. Hematol. 27: 654-662.
39. Yamada, N., H. Matsushima, Y. Tagaya, S. Shimada, and S. I. Katz. 2003. Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. J. Invest. Dermatol. 121: 1425-1432.
40. Ovary, Z. 1965. PCA reaction and its elicitation by specific immunoglobulin species and fragments. Fed. Proc. 24: 94-97.
41. Daëron, M., J. Couderc, M. Ventura, and G.-A. Voisin. 1982. Anaphylactic properties of mouse monoclonal IgG2a antibodies. Cell. Immunol. 70: 27-40.
42. Hirayama, N., T. Hirano, G. Kohler, A. Kurata, K. Okumura, and Z. Ovary. 1982. Biological activities of anti-trinitrophenyl and anti-dinitrophenyl mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA 79: 613-615.
43. Gibbs, B. F., A. Rathling, D. Zillikens, M. Huber, and H. Haas, 2006. Initial FcεRI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J. Allergy Clin. Immunol. 118: 1060-1067.
44. Makabe-Kobayashi, Y., Y. Hori, T. Adachi, S. Ishigaki-Suzuki, Y. Kikuchi, Y. Kagaya, K. Shirato, A. Nagy, A. Ujike, T. Takai, et al. 2002. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J. Allergy Clin. Immunol. 110: 298-303.
45. Binstadt, B. A., P. R. Patel, H. Alencar, P. A. Nigrovic, D. M. Lee, U. Mahmood, R. Weissleder, D. Mathis, and C. Benoist. 2006. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7: 284-292.
46. Bryce, P. J., C. B. Mathias, K. L. Harrison, T. Watanabe, R. S. Geha, and H. C. Oettgen. 2006. The H1 histamine receptor regulates allergic lung responses. J. Clin. Invest. 116: 1624-1632.
47. Hallgren, J., and G. Pejler. 2006. Biology of mast cell tryptase: an inflammatory mediator. FEBS J. 273: 1871-1895.
48. Ossovskaya, V. S., and N. W. Bunnett. 2004. Protease-activated receptors: contribution to physiology and disease. Physiol. Rev. 84: 579-621.
49. Thomas, P. S., D. H. Yates, and P. J. Barnes. 1995. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am. J. Respir. Crit. Care Med. 152: 76-80.
50. Lukacs, N. W., R. M. Strieter, S. W. Chensue, M. Widmer, and S. L. Kunkel. 1995. TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation. J. Immunol. 154: 5411-5417.
51. Amrani, Y., H. Chen, and R. A. Panettieri, Jr. 2000. Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma? Respir. Res. 1: 49-53.
52. Thomas, P. S. 2001. Tumour necrosis factor-α: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol. 79: 132-140.
53. Thornhill, M. H., S. M. Wellicome, D. L. Mahiouz, J. S. Lanchbury, U. Kyan-Aung, and D. O. Haskard. 1991. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells: the contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J. Immunol. 146: 592-598.
54. Berry, M. A., B. Hargadon, M. Shelley, D. Parker, D. E. Shaw, R. H. Green, P. Bradding, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord. 2006. Evidence of a role of tumor necrosis factor α in refractory asthma. N. Engl. J. Med. 354: 697-708.
55. Feldmann, M., and R. N. Maini. 2003. Lasker Clinical Medical Research Award: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9: 1245-1250.
56. Hsu, H. C., Y. Wu, and J. D. Mountz. 2006. Tumor necrosis factor ligand-receptor superfamily and arthritis. Curr. Dir. Autoimmun. 9: 37-54.